Effect of Neoadjuvant Chemo‐Hormonal Therapy on Reducing Recurrence in Patients With Very High‐Risk Prostate Cancer Undergoing Robot‐Assisted Radical Prostatectomy
Neoadjuvant chemo-hormonal therapy before robot-assisted radical prostatectomy resulted in favorable biochemical progression-free survival rates in patients with very high-risk prostate cancer. This result suggests that this therapeutic approach has potential for becoming a new standard of care.
Authors
- Karen Makishima
- Emika Moriyasu
- Ryoma Nishikawa (ORCID: https://orcid.org/0000-0001-6787-9601)
- Yoshihisa Umekita (ORCID: https://orcid.org/0000-0002-2846-390X)
- N Yamaguchi
- Yuri Koyama (ORCID: https://orcid.org/0009-0002-3427-7078)
- Rumiko Omatsu
- Hiroshi Yamane
- Atsushi Yamamoto
- Takahiro Hoshino
- Yusuke Kimura
- Atsushi Takenaka
- Shuichi Morizane
- Katsuya Hikita
Institutions
- Tottori University of Environmental Studies (JP)
- Tottori University (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1111/iju.70387
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00